By Jon Rappoport
“Newborn Screening in America,” a report from the Council for Responsible Genetics, states: “Before they are even a week old, ninety-eight percent of the 4.3 million babies born annually in the United States have a small sample of blood taken from their heels.”
The report continues: “These newborn bloodspots (NBS) are then screened for a variety of inherited conditions and may later be stored in state-operated databases…parents are often unaware of these screening programs and their consent options.”
This shocking national program, flying under the radar, is of course explained as a humane medical undertaking. But there is no across-the-board genetic treatment for any disease or illness. All the “maybe-possibly-in-the-future-cure” nonsense does nothing to justify this rank incursion on newborns and their unsuspecting families.
The report goes on: “With respect to [bloodspot] sample storage and use, there is also little transparency regarding storage procedures or the use of the samples after they have been screened…many states do not have clearly articulated policies about consent for the storage and use of samples or may not effectively communicate these policies to parents.”